Stephanie Johnson

Stephanie Johnson is a Principal Scientist in Formulation Development at Pfizer, with a robust background in synthetic organic chemistry, analytical chemistry, and drug product formulation. Johnson previously contributed as a Postdoctoral Researcher and Graduate Research Assistant at The University of Kansas, where they focused on synthesizing novel antibiotics and designing polymer-antigen conjugates for diabetes treatment. They began their research career as an Undergraduate Research Program Participant at the same institution, working on polymeric nanoparticles. Johnson also gained experience as a Summer Student Research Participant at the FDA, analyzing pharmaceuticals to ensure compliance with USP criteria. They hold a PhD in Pharmaceutical Chemistry from The University of Kansas, along with multiple degrees in related fields.